You Have Questions, We Have Answers. Read More
Archive
Filter
Few trends boast as much momentum as global demand for health services. We examine the benchmark ETF for this fast-growing sector. Read More
To generate wealth, you need to adopt the right mindset. Read More
A top Investing Daily analyst discusses timely investment topics. Read More
Changes in the government’s regulatory stance should benefit these stocks. Read More
Discounted cash flow models overstate temporary conditions. Read More
Merck and AbbVie should be immune to changes at the FDA and any future ACA replacement. Read More
Our two banks should fare better than most due to diversified income streams. Read More
There is now twice as much downside risk as there is upside potential in APU, so it's time to sell AmeriGas Partners Read More
This month’s Personal Finance options recommendation includes two strategies, selling a covered call and selling a naked put on Merck & Co. (NYSE: MRK) as described below. If you already own shares of Merck & Co., then you should consider selling a covered call against that stock position, but if… Read More